An Integrative Approach to CTL Epitope Prediction: a Combined Algorithm Integrating MHC Class I Binding, TAP Transport Efficiency, and Proteasomal Cleavage Predictions
Overview
Authors
Affiliations
Reverse immunogenetic approaches attempt to optimize the selection of candidate epitopes, and thus minimize the experimental effort needed to identify new epitopes. When predicting cytotoxic T cell epitopes, the main focus has been on the highly specific MHC class I binding event. Methods have also been developed for predicting the antigen-processing steps preceding MHC class I binding, including proteasomal cleavage and transporter associated with antigen processing (TAP) transport efficiency. Here, we use a dataset obtained from the SYFPEITHI database to show that a method integrating predictions of MHC class I binding affinity, TAP transport efficiency, and C-terminal proteasomal cleavage outperforms any of the individual methods. Using an independent evaluation dataset of HIV epitopes from the Los Alamos database, the validity of the integrated method is confirmed. The performance of the integrated method is found to be significantly higher than that of the two publicly available prediction methods BIMAS and SYFPEITHI. To identify 85% of the epitopes in the HIV dataset, 9% and 10% of all possible nonamers in the HIV proteins must be tested when using the BIMAS and SYFPEITHI methods, respectively, for the selection of candidate epitopes. This number is reduced to 7% when using the integrated method. In practical terms, this means that the experimental effort needed to identify an epitope in a hypothetical protein with 85% probability is reduced by 20-30% when using the integrated method. The method is available at http://www.cbs.dtu.dk/services/NetCTL. Supplementary material is available at http://www.cbs.dtu.dk/suppl/immunology/CTL.php.
Computational biology and artificial intelligence in mRNA vaccine design for cancer immunotherapy.
Imani S, Li X, Chen K, Maghsoudloo M, Jabbarzadeh Kaboli P, Hashemi M Front Cell Infect Microbiol. 2025; 14:1501010.
PMID: 39902185 PMC: 11788159. DOI: 10.3389/fcimb.2024.1501010.
Baig S, Berikkara A, Khalid R, Subhan S, Abbas T, Abidi S Front Microbiol. 2025; 15:1498069.
PMID: 39881992 PMC: 11774985. DOI: 10.3389/fmicb.2024.1498069.
Multi-epitope vaccines: a promising strategy against viral diseases in swine.
Chen X, Li Y, Wang X Front Cell Infect Microbiol. 2025; 14():1497580.
PMID: 39760092 PMC: 11695243. DOI: 10.3389/fcimb.2024.1497580.
Mi X, Li S, Ye Z, Dai Z, Ding B, Sun B Front Immunol. 2024; 15:1478201.
PMID: 39669561 PMC: 11634944. DOI: 10.3389/fimmu.2024.1478201.
analysis for the development of multi-epitope vaccines against .
Yun J, Kim A, Kim S, Shin E, Ha S, Kim D Front Immunol. 2024; 15:1474346.
PMID: 39624097 PMC: 11609213. DOI: 10.3389/fimmu.2024.1474346.